COVID-19 Related Acute Macular Neuroretinopathy (AMN): A Case Series

Abstract

Purpose

Following the emergence of coronavirus disease 2019 (COVID-19) eye care practitioners have become accustomed to identifying and managing an array of ocular complications following the viral infection. Acute macular neuroretinopathy (AMN) is one such complication that has been reported. While the etiology of AMN has eluded researchers, current literature is suggestive of a microvascular compromise within the deep capillary plexus of the retina.

Observations

In this case series, we aim to explore two individual cases of presumed AMN following confirmed COVID-19 infection. Our observations and findings support the diagnosis of AMN following the criteria outlined in literature.

Conclusion and Importance

Although acute macular neuroretinopathy is rare, it should be considered by clinicians when considering diagnosis. With the changing landscape of the pandemic, careful and thorough history and testing are key in the diagnosis of AMN.

Keywords:

• COVID-19
• acute macular retinopathy
• neuroretinopathy

Patient Consent

Patient 1: The patient consented to publication of the case and has signed the consent form.

Patient 2: The patient consented to publication of the case and has signed the consent form.

Publication

No institutional approval required.

Disclosure

The following authors have no financial disclosures: T.V, M.S, S.M, W.S

Additional information

Funding

No funding or grant support.